Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Graefes Arch Clin Exp Ophthalmol ; 261(6): 1701-1712, 2023 Jun.
Article in English | MEDLINE | ID: mdl-36625929

ABSTRACT

PURPOSE: To compare macular damage in glaucomatous optic neuropathy (GON) and compressive optic neuropathy (CON) and assess its diagnostic accuracy in distinguishing between diseases. METHODS: Observational, cross-sectional, single-center study. Patients with GON, CON, and healthy controls were included according to the eligibility criteria. An automated spectral-domain optical coherence tomography (SD-OCT) algorithm was used to segment the circumpapilary retinal nerve fiber layer (cpRNFL) and macula. The layer thickness was measured in each sector according to the Early Treatment Diabetic Retinopathy Study and the 6-sector Garway-Heath-based grids. Data was compared across all study groups, and the significance level was set at 0.05. RESULTS: Seventy-five eyes of 75 participants, 25 with GON, 25 with CON, and 25 healthy controls (CG), were included. Macular thickness was diminished in the ganglion cell complex of GON and CON patients compared to CG (p<0.05). The best Garway-Heath-based grid parameters for distinguishing GON and CON were the nasal-inferior (NI) and nasal-superior sectors and the NI/temporal inferior (TI) damage ratios in the macular ganglion cell (mGCL) and inner plexiform (IPL) layers. Moreover, the combination of the NI sector and NI/TI damage ratios in both layers had higher discriminative power (AUC 0.909; 95% CI 0.830-0.988; p<0.001) than combining parameters in each layer separately. CONCLUSION: Our findings suggest that the evaluation of macular segmented layers damage by SD-OCT may be a helpful add-on tool in the differential diagnosis between GON and CON.


Subject(s)
Glaucoma , Macula Lutea , Optic Disk , Optic Nerve Diseases , Humans , Cross-Sectional Studies , Retinal Ganglion Cells , Nerve Fibers , Optic Nerve Diseases/diagnosis , Glaucoma/diagnosis , Tomography, Optical Coherence/methods
2.
Acta Med Port ; 33(10): 685-688, 2020 Oct 01.
Article in English | MEDLINE | ID: mdl-33135624

ABSTRACT

Percutaneous coronary intervention is a coronary revascularization procedure that may rarely result in thromboembolic events. Although infrequent, ophthalmological complications of percutaneous interventions include a wide range of clinical presentations, with differing severity and outcomes. In this case report, an 83-year-old woman, with multiple cardiovascular risk factors, presents with horizontal diplopia after a percutaneous transluminal coronary angioplasty. After ophthalmological evaluation and a head computed tomography scan, the diagnosis of isolated ischemic internuclear ophthalmoplegia was established. After six months of follow-up, the patient showed complete recovery of her symptoms and ocular movements. We discuss the post-percutaneous intervention ophthalmic complications that, although uncommon, must be recognized by health care providers.


A intervenção coronária percutânea é um procedimento de revascularização coronária que pode, raramente, resultar em eventos tromboembólicos. Apesar de incomuns, as complicações oftalmológicas da intervenção percutânea incluem um largo espectro de manifestações clínicas com diferentes prognósticos. Reportamos um caso clínico de uma mulher de 83 anos, com múltiplos fatores de risco cardiovascular, que apresenta diplopia horizontal após uma angioplastia coronária percutânea. O diagnóstico de oftalmoplegia internuclear isquémica isolada foi estabelecido após avaliação oftalmológica e realização de tomografia computorizada cranioencefálica. Seis meses após a apresentação, a doente apresentava recuperação completa dos sintomas e dos movimentos oculares. Os autores discutem as complicações oftalmológicas da intervenção percutânea que, apesar de incomuns, devem ser reconhecidas pelos profissionais de saúde.


Subject(s)
Angioplasty, Balloon, Coronary/adverse effects , Diplopia/etiology , Ophthalmoplegia/etiology , Aged, 80 and over , Female , Head/diagnostic imaging , Humans , Myocardial Revascularization , Tomography, X-Ray Computed , Treatment Outcome
3.
Neuroophthalmology ; 44(2): 76-88, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32395154

ABSTRACT

Observing optic disc pallor during a patient's first visit frequently raises a diagnostic challenge, particularly in regards to whether the cause is due to glaucoma or another form of optic neuropathy. Bruch's membrane opening (BMO) was recently discovered as the anatomical border of the optic disc. BMO minimum rim width (BMO-MRW) seems to be a reliable representation of the neuroretinal rim. In our study, we demonstrate the ability of BMO-MRWs to differentiate between glaucomatous and non-glaucomatous. Additionally, we propose an MRW ratio which may allow discrimination of open angle glaucoma from either non-arteritic anterior ischaemic optic neuropathy or compressive optic neuropathy.

5.
Acta Reumatol Port ; 44(2): 151-154, 2019.
Article in English | MEDLINE | ID: mdl-31455751

ABSTRACT

INTRODUCTION: We report a 9-year follow-up of a child with refractory juvenile idiopathic arthritis (JIA) with associated uveitis in which tocilizumab proved to be effective in achieving disease control. CASE REPORT: A 16-month child was diagnosed with JIA and at the age of 3 developed bilateral non-granulomatous anterior uveitis. Throughout the follow-up, the patient presented frequent joint and ocular flares. Refractory anterior uveitis and topical corticosteroid therapy resulted in the development of bilateral cataract and high intraocular pressure (IOP). The patient underwent multiple ocular surgeries along with corticosteroids, immunosuppressive therapy with Methotrexate and Adalimumab failing to reach disease control. Only after the introduction of Tocilizumab a lower disease activity was achieved. DISCUSSION: Management of JIA-associated uveitis is challenging and requires a close collaboration between paediatric rheumatologists and ophthalmologists. Clinical remission can be difficult to achieve. However, one should always pursuit JIA inactivity with IOP and inflammation control. This report supports Tocilizumab as a useful therapeutic option for JIA-associated uveitis.


Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Arthritis, Juvenile/complications , Uveitis, Anterior/drug therapy , Adrenal Cortex Hormones/adverse effects , Ankle Joint , Cataract/etiology , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Knee Joint , Ocular Hypertension/drug therapy , Ocular Hypertension/etiology , Time Factors , Uveitis, Anterior/etiology
6.
J Curr Glaucoma Pract ; 11(2): 38-41, 2017.
Article in English | MEDLINE | ID: mdl-28924336

ABSTRACT

AIM: To compare the effect of 30-gauge vs 27-gauge needle size on intraocular pressure (IOP) rise and patients' pain experience after intravitreal injection (IVI) of bevacizumab. MATERIALS AND METHODS: Cross-sectional, randomized, double-armed study. Patients were randomized to IVI with 30-gauge or 27-gauge needle. The IOP was measured pre and post IVI. Patients' pain was graded using the visual analog scale (VAS). RESULTS: A total of 54 eyes were included. The IVI caused a significant IOP rise in both groups (p < 0.001). In the 30-gauge group, the mean pre- and postinjection IOP was 16.3 ± 3.6 mm Hg and 24.1 ± 9.0 mm Hg. The corresponding figures in the 27-gauge group were 18.0 ± 2.54 (p = 0.26) and 23.1 ± 7.5 mm Hg (p = 0.66). In the 30-gauge group, the mean VAS pain score was 3.2 ± 2.6 compared to 3.0 ± 2.5 in the 27-gauge group (p = 0.78). CONCLUSION: The IVI caused a significant rise in IOP after the injection, independently of the needle size used. The 27-gauge needle coursed with lower postinjection IOP without prejudice of the patient comfort. CLINICAL SIGNIFICANCE: The IVI with 27-gauge may be considered for glaucomatous eyes (higher risk eyes), for which IOP spikes are not recommended. HOW TO CITE THIS ARTICLE: Loureiro M, Matos R, Sepulveda P, Meira D. Intravitreal Injections of Bevacizumab: The Impact of Needle Size in Intraocular Pressure and Pain. J Curr Glaucoma Pract 2017;11(2):38-41.

8.
Eur J Ophthalmol ; 27(4): 428-432, 2017 Jun 26.
Article in English | MEDLINE | ID: mdl-28009408

ABSTRACT

PURPOSE: To assess the impact of metabolic syndrome (MetS) on the peripapillary choroidal thickness (PPCT) and to characterize the PPCT in a Portuguese population. METHODS: This prospective study included 104 eyes. Detailed medical and ophthalmic examinations were performed; the PPCT was measured by spectral-domain optical coherence tomography (SD-OCT) using enhanced depth imaging (EDI) modality. The PPCT changes with MetS, as well as with other clinical and demographic factors, were investigated. RESULTS: The mean PPCT was 142.4 ± 54.0 µm (58-303 µm); it was thickest superiorly, followed by the temporal, nasal, and inferior sectors. The PPCT was significantly associated with axial length (p<0.001), age (p = 0.001), intraocular pressure (IOP) (p = 0.041), weight (p = 0.015), and arterial hypertension (p = 0.044). The presence of MetS was associated with thinner PPCT in all sectors, being statistically significant in the temporal (p = 0.032) and inferotemporal (p = 0.034) sectors. CONCLUSIONS: The choroidal thickness was significantly less in temporal and inferotemporal sectors in patients with MetS than in controls. This may suggest vascular insufficiency around the optic nerve head.


Subject(s)
Choroid/pathology , Metabolic Syndrome/pathology , Tomography, Optical Coherence/methods , Adult , Aged , Asian People , Female , Humans , Intraocular Pressure/physiology , Male , Metabolic Syndrome/physiopathology , Middle Aged , Portugal , Prospective Studies , Regression Analysis , Tonometry, Ocular , Visual Acuity/physiology
9.
J Neuroophthalmol ; 36(3): 275-9, 2016 09.
Article in English | MEDLINE | ID: mdl-27261948

ABSTRACT

BACKGROUND: In multiple sclerosis (MS), even in the absence of a clinical episode of optic neuritis (ON), the optic nerve and retinal nerve fiber layer (RNFL) may be damaged leading to dyschromatopsia. Subclinical dyschromatopsia has been described in MS associated with lower motor and cognitive performances. OBJECTIVES: To set the prevalence of dyschromatopsia in eyes of MS patients without a history of ON, to compare its prevalence in patients with and without ON history, and to explore the association between dyschromatopsia and disease duration, average peripapillary RNFL thickness, macular volume, and cognitive and motor performances. METHODS: An observational cross-sectional study was conducted at multiple medical centers. Data were collected after single neurological and ophthalmological evaluations. Dyschromatopsia was defined by the presence of at least 1 error using Hardy-Rand-Rittler plates. RESULTS: In our population of 125 patients, 79 patients (63.2%) never had ON and 35 (28.8%) had unilateral ON. The prevalence of dyschromatopsia in eyes of patients without ON was 25.7%. Patients with dyschromatopsia had a statistically significant lower RNFL thickness (P = 0.004 and P = 0.040, right and left eyes, respectively) and worse performance in symbol digit modalities test (P = 0.012). No differences were found in macular volume or motor function tasks. CONCLUSIONS: Dyschromatopsia occurs frequently in MS patients. It may be associated with a worse disease status and possibly serve as a marker for the detection of subclinical disease progression since it was detected even in the absence of ON. It correlated with thinner peripapillary RNFL thickness and inferior cognitive performance.


Subject(s)
Color Vision Defects/etiology , Color Vision/physiology , Multiple Sclerosis/complications , Optic Neuritis/complications , Tomography, Optical Coherence/methods , Visual Acuity , Adolescent , Adult , Color Vision Defects/diagnosis , Color Vision Defects/physiopathology , Cross-Sectional Studies , Disease Progression , Female , Humans , Male , Middle Aged , Multiple Sclerosis/diagnosis , Nerve Fibers/pathology , Optic Nerve/pathology , Optic Neuritis/diagnosis , Retinal Ganglion Cells/pathology , Young Adult
10.
J Neuroophthalmol ; 36(3): 280-4, 2016 09.
Article in English | MEDLINE | ID: mdl-27261947

ABSTRACT

BACKGROUND: Idiopathic intracranial hypertension (IIH) is a well-characterized syndrome, most commonly affecting obese women of childbearing age. Differences in its prevalence have been reported in various populations. The aim of this article was to determine whether differences in clinical presentation and management exist for patients with IIH between different regions the world. METHODS: Retrospective database analysis of adult patients with IIH from 4 different neuro-ophthalmology clinics. The data collected included gender, age of onset, body mass index (BMI), lumbar puncture opening pressure, initial visual acuity (VA), initial visual field (VF) mean deviation (MD), pharmacological or surgical treatment, length of follow-up, final VA, and final VF MD. RESULTS: The study population consisted of 244 patients, with significant regional variations of female to male ratio. Overall, there was no significant difference regarding the age of diagnosis or the BMI. Acetazolamide was the first line of treatment in all groups but there was a difference between countries regarding second-line treatment, including the use of surgical interventions. Mean initial VA differed between groups but the final change in VA was the same among all the study groups. CONCLUSIONS: There are differences in IIH presentation, treatment, and response to therapy among different countries. International prospective studies involving multiple centers are needed to determine the potential influence of environmental and genetic factors on the development of IIH and to improve the management of this potentially blinding disorder.


Subject(s)
Intracranial Pressure/physiology , Pseudotumor Cerebri/diagnosis , Risk Assessment , Visual Acuity , Visual Fields/physiology , Adult , Age of Onset , Female , Humans , Israel/epidemiology , Male , Portugal/epidemiology , Prevalence , Pseudotumor Cerebri/epidemiology , Pseudotumor Cerebri/physiopathology , Retrospective Studies , Spinal Puncture , Switzerland/epidemiology , Turkey/epidemiology
11.
J Clin Diagn Res ; 9(8): NC08-11, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26435977

ABSTRACT

BACKGROUND: During pregnancy the maternal choroid is exposed to the multiple haemodynamic and hormonal alterations inherent to this physiological condition. These changes may influence choroidal anatomy. In this study a quantitative assessment of overall choroidal structure is performed, by constructing a 3-dimensional topographic map of this vascular bed. PURPOSE: To compare the thickness and volume of the maternal choroidal in the third trimester of pregnancy with that of an age-matched control group of women. MATERIALS AND METHODS: Twenty-four eyes of 12 pregnant women in the last trimester and 12 age-matched healthy controls (24 eyes) were included. Optical coherence tomography in enhanced depth imaging mode was used to construct maps of the choroid of the macular area. Choroidal thickness and volume were automatically calculated for the 9 subfields defined by the Early Treatment Diabetic Retinopathy Study (ETDRS). A comparative analysis between the two groups was performed using the two-way ANOVA test. RESULTS: The average thickness of the choroid for the entire ETDRS area of the pregnant group was 295.15 ±42.40µm and 271.56 ±37.65µm in the control group (p=0.051). The average choroidal volume was 8.05 ±1.12mm(3) and 7.46 ±1.03mm(3), respectively (p=0.067). Although the choroid of the pregnant group had larger thickness and volume in all subfields compared to the control group, this difference was statistically significant only in three regions - the central subfield, minimum foveal thickness and inferior inner macula (p<0.05). CONCLUSION: Our study suggests that in the third trimester of pregnancy the choroid may be subjected to physiological changes in structure. Whether these changes are a result of hormonal and/or haemodynamic adaptations of pregnancy remains to be studied.

12.
Retin Cases Brief Rep ; 9(3): 210-3, 2015.
Article in English | MEDLINE | ID: mdl-25719936

ABSTRACT

PURPOSE: To report a case of uncontrolled proliferative diabetic retinopathy as an initial manifestation of chronic myeloid leukemia. METHODS: Case report. PATIENTS: A 55-year-old man with moderate nonproliferative diabetic retinopathy who rapidly developed proliferative retinopathy and bilateral neovascular glaucoma despite good glycemic control. CONCLUSION: Other pathologies should be excluded in diabetic patients with a rapid and severe progression in their retinopathy despite adequate metabolic control. These patients should be treated promptly and aggressively until systemic disease is stable.


Subject(s)
Diabetes Mellitus, Type 2/complications , Diabetic Retinopathy/etiology , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/complications , Humans , Male , Middle Aged
13.
Rev. bras. oftalmol ; 71(4): 245-249, jul.-ago. 2012. ilus, tab
Article in Portuguese | LILACS | ID: lil-650658

ABSTRACT

OBJETIVO: Estudar por biomicroscopia ultrassônica (UBM) de alta frequência as características anatômicas da viscocanalostomia, e a relação dessas características com a redução da pressão intraocular. MÉTODOS: Estudo transversal, que incluiu nove olhos (sete pacientes) submetidos à viscocanalostomia, e posteriormente examinados por UBM de alta frequência (80 MHz). Os parâmetros da UBM avaliados após um follow-up mínimo de seis meses foram: presença de espaço intraescleral, comprimento e altura máximos do espaço intraescleral, e a espessura mínima da membrana trabéculo-descemética (MTD) residual. O sucesso cirúrgico definiu-se como pressão intraocular (PIO) <22mmHg ou redução de 20% da PIO sem medicação tópica. Possíveis associações entre as variáveis da UBM e o resultado cirúrgico foram avaliados. RESULTADOS: O tempo médio entre a cirurgia e a realização da UBM foi de 15,5 ± 8,8 meses (6 - 29 meses). Verificou-se uma redução da PIO de 23,5 ± 6,9 mmHg (13,7-32,0) pré-operatória para 14,5 ± 2,4 mmHg (10,7-17,3) pós-operatória (p<0,05). Identificou-se a presença de espaço intraescleral em todos os olhos. A média do comprimento máximo do espaço intraescleral era 1,83 ± 0,51mm; a média da altura máxima do espaço intraescleral era 0,36 ± 0,17mm; e a média da espessura mínima da MTD era 0,14 ± 0,07mm. Não foram encontradas correlações significativas entre o valor da PIO pós-operatória e o comprimento do espaço intraescleral (r²=0,359), a altura do espaço intraescleral (r²=0,017) e a espessura da MTD (r²=0,003). CONCLUSÃO: Em pacientes submetidos à viscocanalostomia, a UBM após um follow-up mínimo de seis meses identificou o espaço intraescleral em todos os olhos. Não se encontrou qualquer correlação estatisticamente significativa entre os valores de PIO pós-operatória e as características anatômicas do espaço intraescleral.


PURPOSE: To evaluate by high frequency ultrasound biomicroscopy (UBM) the anatomical characteristics of viscocanalostomy and their relationship with the intraocular pressure (IOP) lowering. METHODS: A transversal study which included 9 eyes (7 patients) undergoing viscocanalostomy and examined by high frequency UBM (80 MHz). Several UBM variables were evaluated, including the presence of the intrascleral space, the maximum length and height of the intrascleral space and the minimum thickness of residual trabeculo-Descemet membrane (TDM). Surgical success was considered to be achieved when IOP was <22mmHg or the IOP was lowered 20% or more without the use of any medication. The possible association between UBM variables and the surgical outcome was determined. RESULTS: The mean time between surgery and the UBM examination was 15.5 ± 8.8 months (range 6-29). The mean IOP decreased from a preoperative value of 23.5 ± 6.9 mmHg (range 13.7-32.0) to 14.5 ± 2.4 mmHg (range 10.7-17.3) postoperative (p<0.05). The presence of an intrascleral space was a constant finding. The mean length of the intrascleral space was 1.83 ± 0.51mm, the mean height was 0,36 ± 0,17mm; and the mean TDM thickness was 0.14 ± 0.07mm. There were a poor correlation between the level of IOP at the time of UBM and the lenght of the intrascleral space (r²=0.359), the height of the intrascleral space (r²=0.017) or the thickness of the remaining TDM (r²=0.003). CONCLUSION: In patients undergoing viscocanalostomy, UBM examination after a minimum of 6-month follow-up period showed the presence of an intrascleral space in all patients. There was no statiscally significant relationship between the level of IOP and the anatomical characteristics of the intrascleral space.


Subject(s)
Humans , Male , Female , Middle Aged , Aged, 80 and over , Filtering Surgery/methods , Sclera , Glaucoma, Open-Angle/surgery , Ocular Hypertension/surgery , Intraocular Pressure , Bowman Membrane , Viscoelastic Substances/therapeutic use , Cross-Sectional Studies , Treatment Outcome
16.
Surv Ophthalmol ; 51(6): 587-91, 2006.
Article in English | MEDLINE | ID: mdl-17134648

ABSTRACT

An 18-year-old girl presented with an acute acquired comitant esotropia. Investigation showed a brainstem glioma. Discussion of types of acute acquired comitant esotropia, differential diagnosis and neurologic work-up is given. Review of the literature involving acute acquired comitant esotropia is provided.


Subject(s)
Brain Stem Neoplasms/pathology , Diplopia/etiology , Esotropia/etiology , Glioma/pathology , Intracranial Hypertension/etiology , Acute Disease , Adolescent , Antineoplastic Agents/therapeutic use , Brain Stem Neoplasms/drug therapy , Brain Stem Neoplasms/radiotherapy , Diagnosis, Differential , Female , Gefitinib , Glioma/drug therapy , Glioma/radiotherapy , Humans , Magnetic Resonance Imaging , Quinazolines/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...